Third Security’s Tempest Therapeutics TPST Stock Holding History

Third Security’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-128	Closed	-$303K	–	15
2018 Q1	$303K	Hold	128	–	–	0.02%	15
2017 Q4	$523K	Hold	128	–	–	0.04%	15
2017 Q3	$530K	Hold	128	–	–	0.03%	15
2017 Q2	$582K	Hold	128	–	–	0.03%	15
2017 Q1	$698K	Hold	128	–	–	0.04%	16
2016 Q4	$571K	Hold	128	–	–	0.03%	16
2016 Q3	$2.67M	Hold	128	–	–	0.12%	14
2016 Q2	$1.94M	Hold	128	–	–	0.1%	17
2016 Q1	$3.54M	Hold	128	–	–	0.14%	16
2015 Q4	$3.65M	Hold	128	–	–	0.15%	14
2015 Q3	$3.17M	Hold	128	–	–	0.13%	16
2015 Q2	$10.8M	Hold	128	–	–	0.28%	10
2015 Q1	$13M	Hold	128	–	–	0.36%	10
2014 Q4	$16.5M	Hold	128	–	–	0.75%	10
2014 Q3	$6.2M	Hold	128	–	–	0.39%	14
2014 Q2	$3.42M	Hold	128	–	–	0.16%	17
2014 Q1	$3.34M	Buy	128 +35	+38%	+$992K	0.15%	18
2013 Q4	$2.5M	Buy	+93	New	+$2.55M	0.12%	19

Other funds holding TPST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Third Security's TPST Position: Q2 2018 in Review

Third Security sold out of Tempest Therapeutics (TPST) in Q2 2018, closing a stake of 128 shares — an estimated $303K sold.

Third Security first reported a position in TPST in Q4 2013 and held it in 18 quarters. The position peaked at $16.5M in Q4 2014. 33 funds tracked by Wall St. Rank hold TPST as of Q2 2018.

Third Security reported no remaining Tempest Therapeutics position as of Q2 2018 after selling out during the quarter.
Third Security sold 128 Tempest Therapeutics shares in Q2 2018, an estimated $303K.
Third Security first reported a position in Tempest Therapeutics in Q4 2013 and held it in 18 quarters.
Third Security's Tempest Therapeutics position peaked at $16.5M in Q4 2014.
33 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2018.

Based on Third Security's 13F filing for Q2 2018, filed 30 Jul 2018.